Ely Benaim - May 27, 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Medical Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Ely Benaim
Stock symbol
NVCR
Transactions as of
May 27, 2021
Transactions value $
-$279,423
Form type
4
Date filed
5/28/2021, 04:36 PM
Previous filing
May 14, 2021
Next filing
Jul 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $87.2K +1.83K +6.31% $47.56 30.9K May 27, 2021 Direct
transaction NVCR Ordinary Shares Sale -$367K -1.83K -5.93% $200.00* 29.1K May 27, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -1.83K -20% $0.00 7.33K May 27, 2021 Ordinary Shares 1.83K $47.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
F2 Fully vested as of the date hereof.